About Lavybens Pharmaceuticals
Lavybens Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2010. It manufactures pharmaceutical intermediates, supplies impurity standards, and offers contract manufacturing. It operates on a B2B model. Its Indian entity Lavybens Pharmaceuticals Private Limited reported revenue of ₹21.8 Lakh. Lavybens Pharmaceuticals offers products and services including API Intermediate and API Impurity Standards. Its focus areas include Pharmaceuticals, API Manufacturing, Intermediates and Quality Control. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Lavybens Pharmaceuticals Private Limited is a pharmaceutical company based in Hyderabad, India, specializing in manufacturing bulk intermediates and developing active pharmaceutical ingredients. They supply impurity reference standards and provide contract manufacturing and CRO services. The company features advanced manufacturing facilities and extensive RD capabilities, serving the global pharmaceutical market through domestic and international networks.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Website lavybenspharma.com
- Legal Name Lavybens Pharmaceuticals Private Limited
- Date of Incorporation 03 Dec, 2012
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹21.8 Lakh
FY 2023 · -59% YoY
- Net Loss-₹74.9 Lakh
FY 2023 · -343% margin
- EBITDA-₹74.9 Lakh
FY 2023 · -343% margin
Associated legal entities of Lavybens Pharmaceuticals
Lavybens Pharmaceuticals operates through Lavybens Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lavybens Pharmaceuticals Private Limited CIN U24232TG2012PTC084558 | Active | 03 Dec 2012 | Hyderabad, Telangana | ₹0.2 Cr | 3 | View details |
Products & Services of Lavybens Pharmaceuticals
Lavybens Pharmaceuticals offers a comprehensive portfolio of products and services, including API Intermediate and API Impurity Standards.
Manufactures intermediates for active pharmaceutical ingredients development.
Supplies reference standards for testing pharmaceutical impurities.
Board of directors of Lavybens Pharmaceuticals Private Limited (Lavybens Pharmaceuticals)
Lavybens Pharmaceuticals Private Limited is the primary company behind Lavybens Pharmaceuticals. The board of Lavybens Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Venkata Prabhakara Rao Pechetti, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Prabhakara Rao Pechetti DIN 06402540 | Director | 03 Dec 2012 | 13 yrs 11 mo | Lavybens Pharmaceuticals Private Limited |
| Srinivasu Vallem DIN 06402531 | Director | 03 Dec 2012 | 13 yrs 11 mo | Lavybens Pharmaceuticals Private Limited |
| Himabindu Yella DIN 06402530 | Director | 03 Dec 2012 | 13 yrs 11 mo | Lavybens Pharmaceuticals Private Limited |
Financials of Lavybens Pharmaceuticals
Figures of Lavybens Pharmaceuticals Private Limited, the primary company behind Lavybens Pharmaceuticals, for FY 2023. Revenue was ₹21.8 Lakh (-59% year on year). Net loss was -₹74.9 Lakh (-343% margin). EBITDA was -₹74.9 Lakh (-343% margin). Revenue has grown at a compounded annual rate of -27% over three years and -29% over five years.
- ₹21.8 LakhRevenue · FY 2023 · -59% YoY
- -₹74.9 LakhNet loss · -343% margin
- -₹74.9 LakhEBITDA · -343% margin
- ₹1 LakhPaid-up capital
- -27%Revenue CAGR, 3 years
- -29%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lavybens Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lavybens Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Lavybens Pharmaceuticals
Lavybens Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Lavybens Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lavybens Pharmaceuticals
Lavybens Pharmaceuticals was founded in 2010.
Lavybens Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Lavybens Pharmaceuticals, Lavybens Pharmaceuticals Private Limited, reported revenue of ₹21.8 Lakh for FY 2023, down 59% year on year.
Lavybens Pharmaceuticals Private Limited is a pharmaceutical company based in Hyderabad, India, specializing in manufacturing bulk intermediates and developing active pharmaceutical ingredients. They supply impurity reference standards and provide contract manufacturing and CRO services. The company features advanced manufacturing facilities and extensive RD capabilities, serving the global pharmaceutical market through domestic and international networks.
Lavybens Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Lavybens Pharmaceuticals offers API Intermediate and API Impurity Standards.
Lavybens Pharmaceuticals operates through Lavybens Pharmaceuticals Private Limited.
The legal entities of Lavybens Pharmaceuticals currently have 3 directors, including Venkata Prabhakara Rao Pechetti, Srinivasu Vallem, Himabindu Yella.